Breast cancer screenings still best for early detection

October 12, 2017

(HealthDay)—Breast cancer is the second leading cause of cancer death among women in the United States, and routine screenings remain the most reliable way to detect the disease early, a breast cancer expert says.

"Breast can be treated more successfully if detected in its early phases, while it is small and has not yet spread," said Dr. Kathryn Evers, director of mammography at Fox Chase Cancer Center in Philadelphia. "With today's state-of-the-art treatment options and less extensive surgery, patients are experiencing better outcomes."

Older age is a leading risk factor for . Most women are diagnosed after the age of 50. Having certain mutations in the BRCA1 and BRCA2 genes also predispose women to the disease. And there are some lifestyle-related risk factors that can be controlled, such as hormone therapy after menopause, obesity, alcohol intake and physical inactivity, Evers said.

"Having one risk factor or even several doesn't mean a woman will definitely develop breast cancer," she said in a Fox Chase news release. "Women need to become educated about the , especially those they can control, and then adjust their lifestyle accordingly."

Not all women with breast cancer experience the same warning signs of the disease. Symptoms of breast cancer may include:

  • A lump in the breast or armpit.
  • Swelling or thickening in part of the breast.
  • Dimpling or irritation of the skin on the breast.
  • Pain in the breast that doesn't go away.
  • Redness or flaky skin on the breast or nipple.
  • Unusual nipple discharge.
  • A change in the size or shape of the breast.

In some cases, women never develop any of these symptoms, Evers noted.

"All women should know how their breasts look and feel so they can recognize any changes in them. This is an important part of breast health," she said. "But just being familiar with your breasts should never take the place of regular screenings and mammograms. These tests can help find breast cancer in its early stages, even before symptoms appear."

There are three tests often used to look for breast cancer, Evers said.

  • Mammogram: An X-ray of the breast used to examine breast changes. Its effectiveness depends on the size of a and the density of breast tissue. Three-dimensional (3-D) mammography involves X-ray machines that take pictures of thin slices of the breast from different angles, to build a 3-D image.
  • Breast ultrasound: This test is often used along with mammography to screen high-risk women and those with dense tissue.
  • Breast MRI: This test may be used to screen high-risk women and more closely examine a suspicious area detected during a mammogram or an ultrasound.

"I advise to speak with their physician to determine what is right for them," Evers said.

Explore further: Five things everyone should know about breast cancer

More information: The American Cancer Society has more about breast cancer.

Related Stories

Five things everyone should know about breast cancer

October 4, 2017
In 2017, the American Cancer Society estimates more than 250,000 new cases of breast cancer will be diagnosed in the United States, with more than 40,000 deaths. But progress in treatment and early detection has led to improved ...

Breast cancer awareness: What women need to know

September 28, 2016
As national Breast Cancer Awareness Months begins next week, breast health expert Dr. Sharon Koehler of New York Institute of Technology College of Osteopathic Medicine, says women need to know the following five things:

Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?

June 22, 2017
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy ...

Genetic predisposition to breast cancer due to non-brca mutations in ashkenazi Jewish women

July 20, 2017
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article published by JAMA Oncology examines the likelihood of carrying another cancer-predisposing mutation ...

Most women unaware of breast density's effect on cancer risk, study finds

November 21, 2016
Most women don't know that having dense breasts increases their risk for breast cancer and reduces a mammogram's ability to detect cancer, according to a University of Virginia School of Medicine study.

Men develop breast cancer, too

July 8, 2014
(HealthDay)—While rare, breast cancer does occur in men and is often diagnosed at a later age and stage than in women, experts say.

Recommended for you

Researchers artificially generate immune cells integral to creating cancer vaccines

August 14, 2018
For the first time, Mount Sinai researchers have identified a way to make large numbers of immune cells that can help prevent cancer reoccurrence, according to a study published in August in Cell Reports.

Chemicals found in vegetables prevent colon cancer in mice

August 14, 2018
Chemicals produced by vegetables such as kale, cabbage and broccoli could help to maintain a healthy gut and prevent colon cancer, a new study from the Francis Crick Institute shows.

Lymphatic vessels unexpectedly promote the spread of cancer metastases

August 14, 2018
Lymphatic vessels actively contribute to the spread of cancer metastases from various organs. This unexpected realisation is the result of a joint study by researchers from ETH Zurich and the University Hospital Zurich as ...

Ovarian cancer genetics unravelled

August 14, 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease, and could be used to personalise treatment in future.

Researchers uncover a major new vulnerability of childhood leukemia

August 14, 2018
Childhood leukemia is a diagnosis that no family ever wants to endure. While the treatment of most types of leukemia has improved steadily over the years, a few specific types remain very difficult to treat. One of these ...

Stress hormone is key factor in failure of immune system to prevent leukemia

August 14, 2018
The human stress hormone cortisol has been identified by scientists at the University of Kent as a key factor when the immune system fails to prevent leukemia taking hold.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.